Contact Us

Service Line:+86-022-8216-4980

Address:Room 502, Building B15, Wuqing Developmental Area, Tianjin, China

Email:info@kmdbioscience.com

2019 novel coronavirus(2019-nCoV) infection has attracted worldwide attention since the end of 2019. SARS-CoV-2 is a novel virus that first reported in Wuhan, China, in December 2019. It is a large family of viruses that spread from animals to humans and include diseases like Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). As of May 31, 2020, there were more than 5000,000 confirmed cases of COVID-19 and over 350,000 death cases have been reported globally. Up to now, there is no specific antiviral method for treating the COVID-19. Scientists from all countries are working hard to speed up the research and development of vaccines and the approval of antiviral drugs.

 

KMD Bioscience accumulates many years of experience in the fields of antibodies and proteins. In order to assist in the research of SARS-CoV-2, KMD Bioscience has developed comprehensive portfolio of off the shelf products for SARS-CoV-2 research, including different antibody reagents and recombinant proteins. It’s nearly 30 types in our products, especially, we have paired antibodies. KMD Bioscience can not only provide products in small packages, but also carry out industrial-scale mass production. KMD Bioscience strives to provide support for the development of vaccines, and hope the SARS-CoV-2 outbreak has been well controlled soon. 

 

Please find the COVID-19/SARS-CoV-2 antibodies online: http://www.kmdbioscience.com/products/list?t=601&m=COVID-19

COVID-19/SARS-CoV-2 proteins: http://www.kmdbioscience.com/products/list?t=602&m=COVID-19

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z